Organized Money
Organized Money is a podcast about how the business world really works, and how corporate consolidation and monopolies are dominating every sector of our economy. The series is hosted by writers and journalists Matt Stoller and David Dayen, both thought leaders in the antimonopoly movement. Organized Money is a fresh spin on business reporting, one that goes beyond supply and demand curves or odes to visionary entrepreneurs. Each week Matt and David break down the ways monopolies control everything from the food we eat, to the drugs we take, the way we communicate and even how we date. You’ll hear from workers, business leaders, antitrust lawyers, and policymakers who are on the front lines of the fight for open markets and fair competition.
If you care about an economy that is free and open, one not controlled by a handful of corporations, Organized Money is for you. New episodes out every week until the end of the year. Organized Money is a Rock Creek Sound production, from executive producers Ari Saperstein and Ellen Weiss, and senior producer Benjamin Frisch.
Organized Money
The End of United Healthcare For All
Use Left/Right to seek, Home/End to jump to start or end. Hold shift to jump forward or backward.
After the government announced new regulations for Medicare Advantage, the market-based alternative to traditional Medicare, the stocks of healthcare companies that participate in the program plummeted. But why is this popular program in the crosshairs? And are these new Trump Administration rules actually...good?
Today on the show, Olivia Kosloff, senior fellow at the American Economic Liberties Project and creator of the newsletter Acute Condition, joins Matt and David to discuss Medicare Advantage and how a program that was intended to be cheaper for the government than traditional Medicare has become far more expensive. In addition to problems that have plagued the program since its inception, AI is now being used as a new tool for insurers to extract money from the government. They also discuss how insurers are reacting to the new rules, the future of the program, and whether we need Medicare Advantage at all.